Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity
Clinical trial NCT01108601 · UNKNOWN
Trial details
- NCT number
- NCT01108601
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2011-04-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.